Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
May 14, 2024May 15, 2024Chevallard Daniel R.
CFO
BuyLenz Therapeutics, Inc.LENZ$15.68$49,988+50.00%
Feb 27, 2024Feb 28, 2024Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$0.73$2,493-3.22%
Nov 28, 2023Nov 29, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$0.5$1,860-3.63%
Aug 28, 2023Aug 29, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.45$5,092-3.54%
May 25, 2023May 26, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.42$5,160-3.79%
Feb 27, 2023Feb 28, 2023Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.68$6,051-3.89%
Nov 28, 2022Nov 29, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$2.72$9,606-3.96%
Aug 26, 2022Aug 30, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$4.02$14,679-4.25%
May 26, 2022May 27, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$1.9$6,836-4.35%
Feb 28, 2022Mar 02, 2022Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$2.78$11,112-5.01%
Nov 26, 2021Nov 30, 2021Chevallard Daniel R.
CFO
COO
SellViracta Therapeutics, Inc.VIRX$4.81$36,464-9.41%
Jul 01, 2019Jul 02, 2019Chevallard Daniel R.
CFO
SellRegulus Therapeutics Inc.RGLS$1.31$3,500-3.31%
May 15, 2019May 16, 2019Chevallard Daniel R.
CFO
SellRegulus Therapeutics Inc.RGLS$1.41$14,089-11.04%
Apr 01, 2019Apr 03, 2019Chevallard Daniel R.
CFO
SellRegulus Therapeutics Inc.RGLS$0.98$3,192-25.77%
Jul 25, 2017Jul 25, 2017Chevallard Daniel R.
CFO
BuyRegulus Therapeutics Inc.RGLS$0.91$50,000+48.05%